Reduce initial tranche to 30% of target weight (from 50% proposed), maintain reserve tranche at $605, extend stop loss to ~$580 based on 2x ATR

• 28.85x forward earnings multiple with 27% EPS growth assumption is optimistic, not guaranteed
• PEG of 1.33 is above fair value threshold of 1.0 and doesn't account for cyclical downside risk
• Current multiple is ~2 standard deviations above 10-year historical norm
• After 11.5% two-day pop on 2x volume, market has already priced in meaningful bull case
• Price closed at $643.86 above upper Bollinger Band at $643.86, indicating overextension rather than momentum confirmation
• Conservative mean reversion target is middle band at $612
• 50% initial deployment at $622 is too aggressive for current volatility regime
• 14-day ATR is $20.96, meaning $604.89 stop (2.8% below entry) is too tight and vulnerable to noise
• DE holds $59 billion in finance receivables, making it sensitive to 10-year yield at 4.8%
• Q2 FY26 operating margin compressed to 20.8% from 23%, contradicting 'already offset' narrative
• BofA flagged constrained international recovery which the bull thesis dismisses
• Current entry is leveraged bet on AI capex acceleration with no margin for softening

→ vs aggressive: Stacking 4-5 optimistic assumptions (ag cycle, C&F orders, tariff refunds, no margin compression, stable macro) and calling it fair value is hope dressed as analysis, not a guarantee

→ vs aggressive: PEG of 1.33 is not a screaming buy signal; PEG of 1.0 is conventional fair value marker and doesn't account for cyclical risk

→ vs aggressive: Calling a 7-to-1 upside asymmetric is intellectually dishonest; 50% position at $622 with mean reversion to $612 is only 1.7% downside, making the position sizing unjustified for such a small expected move

→ vs neutral: The trader's $604.89 stop loss (2.8% below $622 entry) is too tight given $20.96 ATR; a single bad morning on no fundamental news can invalidate it. ATR-based stop should be ~$580 (2x ATR from entry)

→ vs neutral: Technical setup showing price above upper Bollinger Band at $643.86 is overextension, not momentum confirmation; mean reversion to $612 is a historically common resolution

→ vs aggressive: Macro dismissal of 10-year at 4.8% as 'already priced in' ignores direct connection to $59B finance receivables; farmers finance at market rates and higher yields compress equipment demand

→ vs aggressive: Claiming international softness is 'already offset' contradicts Q2 FY26 margin compression from 23% to 20.8%; the offset isn't full

→ vs aggressive: AI capex structural tailwind provides no margin of safety; any disappointment in hyperscaler infrastructure spend triggers immediate re-rating

BUY

• Initial position sizing should be 35-40% of target weight (reduced from 50%), balancing the aggressive and conservative positions
• Entry zone remains $620-625 for the first tranche; reserve tranche at $600-605 for a deeper add
• Stop moved to close below $599 (just under 50 SMA), filtering intraday volatility while providing structural protection
• Full target weight remains gated on Q4 FY2026 earnings confirmation—the most disciplined element of the original plan
• Valuation is fair-to-slightly-rich; the 27% EPS growth estimate embeds a recovery story that is trajectory but not guaranteed
• ATR of $20.96 makes the $604.89 stop too tight; the $580 stop is too loose and contradicts the breakout thesis
• Macro context is supportive of cyclical exposure but not aggressively so—slow-growth mild reflation favors DE's position
• Q2 FY26 margin compression (23% to 20.8%) followed by Q3 recovery may be a trough inflection, not sustained expansion—Q4 will confirm
• International ag weakness is a real headwind but not a thesis-breaker given DE's revenue diversification
• Portfolio-level risk calibration is needed; 35-40% of DE's target weight may represent the full industrial allocation if cyclicals are already held

→ vs aggressive: Has not addressed the $622 entry with the same rigor as the $647 chase; conflates a disciplined pullback entry with momentum chasing when they are fundamentally different risk propositions with 50% initial sizing being heavy given the volatility regime

→ vs conservative: The $580 stop (2 ATRs from entry) contradicts the technical structure being defended—a stop that far below a breakout entry means the trader is buying a deeper dip, not the breakout itself, making the entry thesis inconsistent

→ vs aggressive: Forward valuation of 28.85x P/E with 27% EPS growth is not 'fair value' but rather a price reflecting an embedded recovery story with execution risk on the ag cycle turn, C&F orders translating to revenue, and margin trajectory

→ vs conservative: PEG of 1.33 being dismissed as 'expensive' misses the nuance that forward estimates carry a full recovery narrative, and the conservative framing of 'premium priced for hope' doesn't account for diversification improving the risk profile